Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaele Calogero

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Frontiers in Immunology|August 23, 2024
In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T lymphocytes and enhances their effector response to tumor-associated antigensSilvia Brugiapaglia, Sara Bulfamante, Claudia Curcio, et al.
BMC Genomics|August 1, 2014
Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkersFederica Riccardo, Maddalena Arigoni, Genny Buson, et al.
Animals : an Open Access Journal From MDPI|November 25, 2023
RNAseq Analysis of Livers from Pigs Treated with Testosterone and Nandrolone Esters: Selection and Field Validation of Transcriptional BiomarkersAlessandro Benedetto, Kamil Šťastný, Nunzia Giaccio, et al.
Blood|August 3, 2016
Ibrutinib inhibits CD20 upregulation on CLL B cells mediated by the CXCR4/SDF-1 axisGabriela Pavlasova, Marek Borsky, Vaclav Seda, et al.
The Journal of Clinical Investigation|March 3, 2004
Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesionsElena Quaglino, Simona Rolla, Manuela Iezzi, et al.
Oncogenesis|November 14, 2021
Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progressionVeronica Giusti, Francesca Ruzzi, Lorena Landuzzi, et al.
Molecular Cancer Therapeutics|April 29, 2010
Transcriptional analysis of an E2F gene signature as a biomarker of activity of the cyclin-dependent kinase inhibitor PHA-793887 in tumor and skin biopsies from a phase I clinical studyGiuseppe Locatelli, Roberta Bosotti, Marina Ciomei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Piroxicam and cisplatin in a mouse model of peritoneal mesotheliomaEnrico P Spugnini, Irene Cardillo, Alessandra Verdina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 6, 2010
Transcriptional profiling of polycythemia vera identifies gene expression patterns both dependent and independent from the action of JAK2V617FWindy Berkofsky-Fessler, Monica Buzzai, Marianne K-H Kim, et al.
Cell Death and Differentiation|January 20, 2025
Epigenetic regulation of HOXA2 expression affects tumor progression and predicts breast cancer patient survivalFatima Domenica Elisa De Palma, Jonathan G Pol, Vincent Carbonnier, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Frontiers in Immunology|August 23, 2024
In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T lymphocytes and enhances their effector response to tumor-associated antigensSilvia Brugiapaglia, Sara Bulfamante, Claudia Curcio, et al.
BMC Genomics|August 1, 2014
Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkersFederica Riccardo, Maddalena Arigoni, Genny Buson, et al.
Animals : an Open Access Journal From MDPI|November 25, 2023
RNAseq Analysis of Livers from Pigs Treated with Testosterone and Nandrolone Esters: Selection and Field Validation of Transcriptional BiomarkersAlessandro Benedetto, Kamil Šťastný, Nunzia Giaccio, et al.
Blood|August 3, 2016
Ibrutinib inhibits CD20 upregulation on CLL B cells mediated by the CXCR4/SDF-1 axisGabriela Pavlasova, Marek Borsky, Vaclav Seda, et al.
The Journal of Clinical Investigation|March 3, 2004
Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesionsElena Quaglino, Simona Rolla, Manuela Iezzi, et al.
Oncogenesis|November 14, 2021
Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progressionVeronica Giusti, Francesca Ruzzi, Lorena Landuzzi, et al.
Molecular Cancer Therapeutics|April 29, 2010
Transcriptional analysis of an E2F gene signature as a biomarker of activity of the cyclin-dependent kinase inhibitor PHA-793887 in tumor and skin biopsies from a phase I clinical studyGiuseppe Locatelli, Roberta Bosotti, Marina Ciomei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Piroxicam and cisplatin in a mouse model of peritoneal mesotheliomaEnrico P Spugnini, Irene Cardillo, Alessandra Verdina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 6, 2010
Transcriptional profiling of polycythemia vera identifies gene expression patterns both dependent and independent from the action of JAK2V617FWindy Berkofsky-Fessler, Monica Buzzai, Marianne K-H Kim, et al.
Cell Death and Differentiation|January 20, 2025
Epigenetic regulation of HOXA2 expression affects tumor progression and predicts breast cancer patient survivalFatima Domenica Elisa De Palma, Jonathan G Pol, Vincent Carbonnier, et al.
Pageof 6